Clinical Trials Directory

Trials / Completed

CompletedNCT05044156

Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Usak State Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The low Histatine-5 (HST-5) level of the saliva can lead to vaginal candidiasis. Because HST-5 level in the saliva can effect vaginal Ph, flora and local defence mechanisms. Histatine-5 is secreted in the parotis and submandibular glands. İt riches histidine amino ascid and have antifungal activity. Salivary proteins and their plasma levels were found as similar in the literature.

Detailed description

Women with regularly menstrual cycle will enroll in the study than will separate two groups: Study group: women with vaginal candidiasis ( diagnosed by clinic and lab.) Control group: women ( not have any vaginal infections candida and others) Saliva samples will be taken from two groups than HST-5 level will be analyzed. Finally HST-5 levels of the two groups will be compared . Women with diabetes, immun deficiency, pregnancy, virgin, menopausal period , premature ovarian failure will be excluded.

Conditions

Interventions

TypeNameDescription
OTHERsalivary samplesalivary sample

Timeline

Start date
2021-10-21
Primary completion
2022-03-06
Completion
2022-03-06
First posted
2021-09-14
Last updated
2022-03-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05044156. Inclusion in this directory is not an endorsement.

Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women (NCT05044156) · Clinical Trials Directory